[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100287569":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":33,"collaborators":7,"id":36,"slug":7,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":7,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":7,"maxAge":7,"enrollmentInfo":42,"targetDuration":45,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":50,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"Peking Union Medical College Hospital","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Yunyun Fei","CONTACT","+8613681125226","feiyunyun2013@hotmail.com",{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},"Wen Zhang","zhangwen91@sina.com",[18],{"facility":5,"status":19,"city":20,"state":21,"zip":22,"country":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"RECRUITING","Beijing","Beijing Municipality","100032","China",{"type":25,"coordinates":26},"Point",[27,28],116.39723,39.9075,{"lat":28,"lon":27},[31,32],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},{"type":34,"investigatorFullName":15,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Professor","100287569",false,"NCT03023371","National Registry of IgG4-RD in China","Inclusion Criteria:\n\n* Conforming to the diagnostic criteria of IgG4-RD (2011);\n\nExclusion Criteria:\n\n* Excluding other mimicing IgG4-RD, including tumors, vasculitis and sarcoidosis.","ALL",{"count":43,"type":44},900,"ESTIMATED","10 Years","OBSERVATIONAL","The aim of this study is to establish a nation-wide cohort study of IgG4-related disease (IgG4-RD) in China.\n\nMethods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established.\n\nEndpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.",[49],"IgG4-Related Disease",[51],"Registry; cohort study; IgG4-related disease","2017-01-23",{"date":54,"type":44},"2017-01-24",{"date":56,"type":7},"2016-12",{"date":58,"type":44},"2026-12",{"name":5,"class":6},1]